AKT1 and atherosclerosis: KEGG enrichment analysis showed that gut microbiota and metabolites regulate COPD mechanisms through signaling pathways such as Lipid and atherosclerosis, IL-17 signaling pathway, NF-kappa B signaling pathway, PI3K-Akt signaling pathway, and JAK–STAT signaling pathway.